WallStreetZenWallStreetZen

NASDAQ: KNSA
Kiniksa Pharmaceuticals International PLC Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Kiniksa Pharmaceuticals International earnings were -$17.0M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest KNSA earnings report on Mar 31, 2025 announced Q1 2025 earnings of $8.5M, down 196.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, KNSA reported annual earnings of -$43.2M, with -406.7% growth. The next KNSA earnings date is Jun 5, 2025.

KNSA earnings history

Current Revenue
$481.2M
Current Earnings
-$17.0M
Current Profit Margin
-3.5%

KNSA Return on Equity

Current Company
-3.8%
Current Industry
1.9%
Current Market
25%
KNSA's Return on Equity (-3.8%)... subscribe to Premium to read more.
High Return on Equity Performance

KNSA undefined

Current Company
-3%
Current Industry
0.9%
KNSA is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when KNSA announces earnings.

KNSA undefined

Current Company
-1.26%
Current Industry
3.6%
KNSA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

KNSA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
KNSA-$1.55M-$16.95MN/A-$0.24
JANX-$66.93M-$68.99MN/A-$1.28
BLTE-$35.67M-$36.14MN/A-$1.18
TARS-$105.85M-$115.55MN/A-$3.07
VCEL$23.28M$10.36M+36.78%$0.21
View Top Biotech Stocks

KNSA earnings dates

Next earnings date
Jun 5, 2025

Kiniksa Pharmaceuticals International Earnings Reports & History FAQ

What were Kiniksa Pharmaceuticals International's earnings last quarter?

On KNSA's earnings call on Invalid Date, Kiniksa Pharmaceuticals International (NASDAQ: KNSA) reported Q1 2025 earnings per share (EPS) of $0.12, up 148% year over year. Total KNSA earnings for the quarter were $8.54 million. In the same quarter last year, Kiniksa Pharmaceuticals International's earnings per share (EPS) was -$0.25.

If you're new to stock investing, here's how to buy Kiniksa Pharmaceuticals International stock.

When does Kiniksa Pharmaceuticals International report earnings?

The next KNSA earnings date is Invalid Date. Add KNSA to your watchlist to be reminded of Kiniksa Pharmaceuticals International's next earnings date.

Is Kiniksa Pharmaceuticals International profitable or losing money?

As of the last Kiniksa Pharmaceuticals International earnings report, Kiniksa Pharmaceuticals International is currently losing money. Kiniksa Pharmaceuticals International's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$16.95 million, a 295.95% decrease year over year.

What was KNSA's earnings growth in the past year?

As of Kiniksa Pharmaceuticals International's earnings date in Invalid Date, Kiniksa Pharmaceuticals International's earnings has grown year over year. KNSA earnings in the past year totalled -$16.95 million.

What are Kiniksa Pharmaceuticals International's earnings expectations?

The current EPS estimate for Kiniksa Pharmaceuticals International's earnings report in Invalid Date is $0.28.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.